KTC
TAK icon

Kistler-Tiffany Companies’s Takeda Pharmaceutical TAK Stock Holding History

Kistler-Tiffany Companies’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$64.5K Sell
4,105
-211
-5% -$3.46K 0.01% 461
2023
Q1 		$71.1K Buy
4,316
+2,352
+120% +$37.5K 0.01% 406
2022
Q4 		$30.6K Buy
+1,964
New +$27.4K 0.01% 475

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kistler-Tiffany Companies's TAK Position: Q2 2023 in Review

Kistler-Tiffany Companies reduced its Takeda Pharmaceutical (TAK) stake by 4.9% in Q2 2023, selling an estimated $3.46K and leaving 4,105 shares worth $64.5K. The position accounts for 0.01% of the portfolio, ranked #461.

Kistler-Tiffany Companies first reported a position in TAK in Q4 2022 and has held it in 3 quarters since. The position peaked at $71.1K in Q1 2023. 311 funds tracked by Wall St. Rank hold TAK as of Q2 2023.

  • Kistler-Tiffany Companies held 4,105 shares of Takeda Pharmaceutical worth $64.5K as of Q2 2023.
  • Kistler-Tiffany Companies sold 211 Takeda Pharmaceutical shares in Q2 2023, an estimated $3.46K.
  • Takeda Pharmaceutical made up 0.01% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #461 holding.
  • Kistler-Tiffany Companies first reported a position in Takeda Pharmaceutical in Q4 2022 and has held it in 3 quarters since.
  • Kistler-Tiffany Companies's Takeda Pharmaceutical position peaked at $71.1K in Q1 2023.
  • 311 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2023.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.